Rifampin 300 MG capsule 60S
Ended Awarded
- Contract number
- SPE2DB25FNAVQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,204
Award facts
- Contract value 100% obligated
- $7,204.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Rifampin 300 mg capsules (60-count units) valued at $7,204.23 under firm fixed pricing. This non-set-aside, competitively awarded delivery order is scheduled for completion by September 19, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under the vendor's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables comprehensive pharmaceutical and medical supply deliveries to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This delivery order for Rifampin—an antibiotic used in treating infections including tuberculosis—aligns with the company's established role as a primary vendor supplying the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through the DLA's Pharmaceutical Prime Vendor program.
Quick answers
Who was awarded contract SPE2DB25FNAVQ?
SPE2DB25FNAVQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FNAVQ worth?
The government has obligated $7,204 on SPE2DB25FNAVQ.
Is contract SPE2DB25FNAVQ an order under another contract?
Yes. SPE2DB25FNAVQ is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FNAVQ competed?
The extent of competition for SPE2DB25FNAVQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award